ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.2074A>C (p.Lys692Gln)

gnomAD frequency: 0.00001  dbSNP: rs730880562
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000158138 SCV000208073 uncertain significance not provided 2013-02-27 criteria provided, single submitter clinical testing p.Lys692Gln (AAG>CAG): c.2074 A>C in exon 22 of the MYBPC3 gene (NM_000256.3)The Lys692Gln variant in the MYBPC3 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Lys692Gln results in a semi-conservative amino acid substitution of a positively charged Lysine with a neutral, polar Glutamine at a position that is conserved across species. Mutations in nearby codons (Gln689His, Ala693Ser, Ala701Thr) have been reported in association with HCM, further supporting the functional importance of this region of the protein. The Lys692Gln variant was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, in silico analysis predicts Lys692Gln is benign to the protein structure/function. With the clinical and molecular information available at this time, we cannot definitively determine if Lys692Gln is a disease-causing mutation or a rare benign variant. Mutations in the MYBPC3 gene have been reported in 20%-30% of patients with autosomal dominant familial hypertrophic cardiomyopathy, and have been reported less frequently in patients with autosomal dominant familial dilated cardiomyopathy (Cirino A et al., 2011; Hershberger R et al., 2009). The variant is found in DCM panel(s).
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001170426 SCV001333004 uncertain significance Cardiomyopathy 2018-05-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.